Animal models for the study of childhood leukemia: Considerations for model identification and optimization to identify potential risk factors

International Journal of Toxicology

Volumn 23, Issue 3, 2004, Pages 149-161

  McCormick, David L ^a   Kavet, Robert ^b  

^a IIT RESEARCH INSTITUTE   (United States)

^b ELECTRIC POWER RESEARCH INSTITUTE   (United States)

Author keywords

Animal Models; Leukemia; Leukemia (Childhood); Leukemia (Pediatric); Multistage Oncogenesis

Indexed keywords

BCR ABL PROTEIN; BENZENE; IMMUNOGLOBULIN HEAVY CHAIN; MYC PROTEIN; PROCARBAZINE; PROTEIN P53; TRANSCRIPTION FACTOR RUNX1;

ANIMAL MODEL; ARTICLE; CHILDHOOD LEUKEMIA; ENVIRONMENTAL FACTOR; GENETIC ENGINEERING; HAZARD ASSESSMENT; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; LEUKEMIA VIRUS; LEUKEMOGENESIS; MATHEMATICAL MODEL; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; POSTNATAL DEVELOPMENT; RADIATION EXPOSURE; RAT; RISK FACTOR; ANIMAL; BIOLOGICAL MODEL; CHILD; DISEASE MODEL; GENETICS; LEUKEMIA;

ANIMALIA;

ANIMALS; CHILD; DISEASE MODELS, ANIMAL; HUMANS; LEUKEMIA; MODELS, GENETIC; RISK FACTORS;

EID: 16544386576     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810490471325     Document Type: Article

References (70)

1. American Cancer Society. 2004. Cancer facts and figures, 2004. Atlanta, GA: American Cancer Society.
2. Andreasson, P., J. Schwaller, E. Anastasiadou, J. Aster, and D. G. Gilliland. 2001. The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo. Cancer Genet. Cytogenet. 130:93-104.
3. Boutwell, R. K. 1964. Some biological aspects of skin carcinogenesis. Prog. Exp. Tumor Res. 4:207-250.
4. Breuer, M., R. Slebos, S. Verbeek, M. van Lohuizen, E. Wientjens, and A. Berns. 1989. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature 340:61-63.
5. Buckley, J. D., C. M. Buckley, N. E. Breslow, G. J. Draper, P. K. Roberson, and T. M. Mack. 1996. Concordance for childhood cancer in twins. Med. Pediatr. Oncol. 26:223-229.
6. Burchenal, J. H. 1975. Murine and human leukemias. Bibl. Haematol. 40:665-677.
7. 190 fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product. Blood 90:2168-2174.
8. Donehower, L. A., M. Harvey, B. L. Slagle, M. J. McArthur, C. A. Montgomery, Jr., J. S. Butel, et al. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221.
9. Dragan, Y. P., and H. C. Pitot. 1992. Multistage hepatocarcinogenesis in the rat: Insights into risk estimation. Prog. Clin. Biol. Res. 374:261-279.
10. Ford, A. M., C. A. Bennett, C. M. Price, M. C. Bruin, E. R. Van Wering, and M. Greaves. 1998. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc. Natl. Acad. Sci. U.S.A. 95:4584-4588.
11. Ford, A. M., S. A. Ridge, M. E. Cabrera, H. Mahmoud, C. M. Steel, L. C. Chan, et al. 1993. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature 363:358-360.
12. Frei, J. V. 1980. Methylnitrosourea induction of thymomas in AKR mice requires one or two "hits" only. Carcinogenesis 1:721-723.
13. Furth, J., H. R. Seibold, and R. R. Rathbone. 1933. Experimental studies on lymphomatosis of mice. Am. J. Cancer 19:521-526.
14. Gale, K. B., A. M. Ford, R. Repp, A. Borkhardt, C. Keller, O. B. Eden, et al. 1997. Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots. Proc. Natl. Acad. Sci. U.S.A. 94:13950-13954.
15. Gulezian, D., D. Jacobson-Kram, C. B. McCullough, H. Olson, L. Recio, D. Robinson, et al. 2000. Use of transgenic animals for carcinogenicity testing: Considerations and implications for risk assesssment. Toxicol. Pathol. 28:482-499.
16. Hariharan, I. K., A. W. Harris, M. Crawford, H. Abud, E. Webb, S. Cory, et al. 1989. A bcr-v-abl oncogene induces lymphomas in transgenic mice. Mol. Cell Biol. 9:2798-2805.
17. Hartley, J. W., N. K. Wolford, L. J. Old, and W. P. Rowe. 1977. A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc. Nat. Acad. Sci. U.S.A. 74:789-792.
18. Harris, A. W., A. Basten, V. Gebski, D. Noonan, J. Finnie, M. L. Bath, et al. 1998. A test of lymphoma induction by long-term exposure of E mu-Pim1 transgenic mice to 50 Hz magnetic fields. Radiat. Res. 149:300-307.
19. Harris, A. W., C. A. Pinkert, M. Crawford, W. Y. Langdon, R. L. Brinster, and J. M. Adams. 1988. The E μ-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells. J. Exp. Med. 167:353-371.
20. Heisterkamp, C., G. Jenster, J. tenHoeve, D. Zovich, P. K. Pattengale, and J. Groffen. 1990. Acute leukaemia in bcr/abl transgenic mice. Nature 344: 251-253.
21. Hiai, H. 1996. Genetic predisposition to lymphomas in mice. Pathol. Int. 46:707-718.
22. bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice. Blood 85:2853-2861.
23. 1-positive Leukemias. Blood 91:2067-2075.
24. Huettner, C. S., P. Zhang, R. A. VanEtten, and D. G. Tenen. 2000. Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat. Genet. 24:57-60.
25. Huff, J. E., J. K. Haseman, D. M. DeMarini, S. Eustis, R. R. Maronpot, A. C. Peters, et al. 1989. Multiple-site carcinogenicity of benzene in Fischer 344 rats and B6C3F1 mice. Environ. Health Perspect. 82:125-163.
26. Jullien, P., and G. Rudali. 1967. Action of x-rays on the leukemogenesis of AKR mice: The role of a general lesion of the hematopoietic system. Int. J. Cancer 2:245-255.
27. Kaplan, H. S., and M. B. Brown. 1952. A quantitative dose-response study of lymphoid tumor development in irradiated C57 black mice. J. Natl. Cancer Inst. 13:185-206.
28. Kawamura, M., A. Kikuchi, S. Kobayashi, R. Hanada, K. Yamamoto, K. Horibe, et al. 1995. Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia. Blood 85:2546-2552.
29. Kawamura, M., H. Ohnishi, S. X. Guo, X. M. Sheng, M. Minegishi, R. Hanada, et al. 1999. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia. Leuk. Res. 23:115-126.
30. Kinlen, L. J. 1995. Epidemiological evidence for an infective basis in childhood leukaemia. Br. J. Cancer 71:1-5.
31. Langdon, W. Y., A. W. Harris, and S. Cory. 1989. Acceleration of B-lymphoid tumorigenesis in E mu-myc transgenic mice by v-H-ras and v-raf but not v-abl. Oncogene Res. 4:253-258.
32. Leder, A., A. Kuo, R. D. Cardiff, E. Sinn, and P. Leder. 1990. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid. Proc. Natl. Acad. Sci. U.S.A. 87:9178-9182.
33. Look, A. T. 1997. Oncogenic transcription factors in the human acute leukemias. Science 278:1059-1064.
34. Lübbert, M., J. Mirro, Jr., C. W. Miller, J. Kahan, G. Isaac, G. Kitchingman, et al. 1990. N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. Blood 75:1163-1169.
35. McCormick, D. L., W. D. Johnson, K. V. Rao, T. Bowman-Gram, V. E. Steele, R. A. Lubet, et al. 1996. Comparative activity of N-(4-hydroxyphenyl)-all- trans-retinamide and alpha-difluoromethylornithine as inhibitors of lymphoma induction in PIM transgenic mice. Carcinogenesis 17:2513-2517.
36. McCormick, D. L., and R. C. Moon. 1985. Tumorigenesis of the rat mammary gland. In Handbook of carcinogen testing, eds. H. Milman and E. K. Weisburger, 215-229. Park Ridge, NJ: Noyes Publications.
37. McCormick, D. L., B. M. Ryan, J. C. Findlay, J. R. Gauger, T. R. Johnson, R. L. Morrissey, et al. 1998. Exposure to 60 Hz magnetic fields and risk of lymphoma in PIM transgenic and TSG-p53 (p53 knockout) mice. Carcinogenesis 19:1649-1653.
38. McWhirter, W. 1982. The relationship of incidence of childhood lymphoblastic leukaemia to social class. Br. J. Cancer 46:640-645.
39. Miller, R. W. 1967. Persons with exceptionally high risk of leukemia. Cancer Res. 27:2420-2423.
40. Mori, H., S. M. Colman, Z. Xiao, A. M. Ford, L. E. Healy, C. Donaldson, et al. 2002. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc. Natl. Acad. Sci. U.S.A. 99:8242-8247.
41. National Toxicology Program. 2004. NTP testing information and study results. Research Triangle Park, NC: National Institute of Environmental Health Sciences. Available at: http://ntp-server.niehs.nih.gov/main_pages/ NTP_ALL_STDY_PG.html.
42. Parkin, D. M., E. Kramárová, G. J. Draper, et al., eds. 1998. International incidence of childhood cancer, Vol. II. IARC Publications, No. 144. Lyon, France: International Agency for Research on Cancer.
43. Pitot, H. C., and Y. Dragan. 2001. Chemical Carcinogenesis. In Casarett & Doull's toxicology, 6th ed., ed. C. D. Klaassen, 241-319, New York: McGraw-Hill.
44. Pui, C.-H., F. G. Behm, S. C. Raimondi, R. K. Dodge, S. L. George, G. K. Rivera, et al. 1989. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N. Engl. J. Med. 321:136-142.
45. Repacholi, M. H., A. Basten, V. Gebski, D. Noonan, J. Finnie, and A. W. Harris. 1997. Lymphomas in E μ-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields. Radiat. Res. 147:631-640.
46. Rhoades, K. L., D. J. Hetherington, N. Harakawa, D. A. Yergeau, L. Zhou, L-Q. Liu, et al. 2000. Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model. Blood 96:2108-2115.
47. Rinsky, R. A. 1989. Benzene and leukemia: An epidemiologic risk assessment. Environ. Health Perspect. 82:189-191.
48. Rogers, A. E., R. Akhtar, and S. H. Zeisel. 1990. Procarbazine carcinogenicity in methotrexate-treated and lipotrope-deficient male rats. Carcinogenesis 11:1491-1495.
49. Rosenbaum, H., E. Webb, J. M. Adams, S. Cory, and A. W. Harris. 1989. N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc. EMBO J. 8:749-755.
50. Ross, J. A., S. M. Davies, J. D. Potter, and L. L. Robison. 1994. Epidemiology of childhood leukemia, with a focus on infants. Epidemiol. Rev. 16:243-272.
51. Smith, M., T. Chen, and R. Simon. 1997. Age-specific incidence of acute lymphoblastic leukemia in US children: In utero initiation model. J. Natl. Cancer Inst. 89:1542-1544.
52. Smith, M. A., L. A. Gloeckler Ries, J. G. Gurney, and J. A. Ross. 1999. Leukemia. In Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995, eds. L. A. G. Ries, M. A. Smith, J. G. Gurney, M. Linet, T. Tamra, J. L. Young, et al. 17-34. Bethesda, MD: National Cancer Institute.
53. Snyder, C. A., A. R. Sellakumar, D. J. James, and R. E. Albert. 1988. The carcinogenicity of discontinuous inhaled benzene exposures in CD-1 and C57B1/6 mice. Arch. Toxicol. 62:331-335.
54. Spalding, J. W., J. Momma, M. R. Elwell, and R. W. Tennant. 1993. Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene. Carcinogenesis 14:1335-1341.
55. Speck, N. A., and D. G. Gilliland. 2002. Core-binding factors in haematopoiesis and leukaemia. Nat. Rev. Cancer 2:502-513.
56. Staudt, L. M. 2002. It's ALL in the diagnosis. Cancer Cell 1:109-110.
57. Steffen, D., S. Bird, W. P. Rowe, and R. A. Weinberg. 1979. Identification of DNA fragments carrying ecotropic proviruses of AKR mice. Proc. Natl. Acad. Sci. U.S.A. 76:4554-4558.
58. Strasser, A., A. W. Harris, M. L. Bath, and S. Cory. 1990. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348:331-333.
59. Tamaoki, N. 2001. The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis. Toxicol. Pathol. 29 (Suppl.):81-89.
60. Tucker, M. A., A. T. Meadows, J. D. Boice, Jr., M. Stovall, O. Oberlin, B. J. Stone, et al. 1987. Leukemia after therapy with alkylating agents for childhood cancer. J. Natl. Cancer Inst. 78:459-464.
61. van Lohuizen, M., S. Verbeek, P. Krimpenfort, J. Domen, C. Saris, T. Radaszkiewicz, et al. 1989. Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell 56:673-682.
62. Wasserman, R., X. X. Zeng, and R. R. Hardy. 1998. The evolution of B precursor leukemia in the E mu-ret mouse. Blood 92:273-282.
63. Wiemels, J. L., G. Cazzaniga, M. Daniottis, O. B. Eden, G. M. Addison, G. Maera, et al. 1999. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet. 354:1499-1503.
64. Wiemels, J. L., B. C. Leonard, Y. Wang, M. R. Segal, S. P. Hunger, M. T. Smith, et al. 2002b. Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. U.S.A. 99:15101-15106.
65. Wiemels, J. L., Z. Xiao, P. A. Buffler, A. T. Maia, X. Ma, B. M. Dicks, et al. 2002a. In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood 99:3801-3805.
66. Yagi, T., S. Hibi, Y. Tabata, K. Kuriyama, T. Teramura, T. Hashida, et al. 2000. Detection of clonotypic IGH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia. Blood 96:264-268.
67. Yefenof, E., and M. Kotler. 1995. Radiation leukemia virus-induced leukemogenesis: A paradigm of preleukemia and its control by preventive therapy. Adv. Cancer Res. 66:293-312.
68. Yokota, S., M. Nakao, S. Horiike, T. Seriu, T. Iwai, H. Kaneko, et al. 1998. Mutational analysis of the N-ras gene in acute lymphoblastic leukemia: A study of 125 Japanese pediatric cases. Int. J. Hematol. 67:379-387.
69. Yuspa, S. H. 1994. The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis. Cancer Res. 54:1178-1189.
70. Zeng, X. X., H. Zhang, R. R. Hardy, and R. Wasserman. 1998. The fetal origin of B-precursor leukemia in the E-mu-ret mouse. Blood 92:3529-3536.